BLSSS 2023 | SynAct Pharma
SynAct Pharma's CEO Torbjørn Bjerke presents the company at BioStock Life Science Spring Summit 2023.
0:00 Introduction
0:53 SynAct in brief
2:10 Pipeline
3:34 SynAct’s compounds
4:59 RA – large medical need
5:57 AP1189-results from first study
8:32 Good safety
9:24 EXPAND phase IIb study
10:16 Proof-of-Concept in another patient group
10:40 Emerging profile of AP1189
12:07 KOL’s opinions
12:31 New indications
12:53 Q&A
Subscribe and follow BioStock on:
YouTube https://bit.ly/Biostock
LinkedIn: / biostock
Facebook: / biostock.se
Twitter: / biostock_swe
https://www.biostock.se/
#BioStock #LifeScience #BLSSS2023 #SynActPharma
About BioStock
BioStock is Scandinavia's leading digital news and analysis service with an exclusive focus on the Life Science sector. Our primary editorial office is found at Medicon Village in Lund, one of Sweden's foremost innovation clusters for life science companies, while our second editorial office is located in central Stockholm with proximity to both life science companies and financial players. We have TV studios on both sites.